Comments
Loading...

Kymera Therapeutics

KYMRNASDAQ
Logo brought to you by Benzinga Data
$50.00
-1.84-3.55%
At close: -
$50.00
00.00%
After Hours: 4:00 PM EDT

Kymera Therapeutics (NASDAQ:KYMR) Stock Quotes, Forecast and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
1
Jul
1
2
Aug
2
Sep
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$51.49
Close$50.00
Volume / Avg.308.74K / 410.52K
Day Range$49.12 - $52.49
52 Wk Range13.85 - 53.27
Market Cap$3.24B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
57
Short Interest
15.79%
Days to Cover25.08

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
KYMR
IMVT

FAQ

Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ:KYMR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kymera Therapeutics (KYMR) competitors?

Q

What is the forecast, or price target, for Kymera Therapeutics (KYMR) stock?

A

Kymera Therapeutics has a consensus price target of $48.38.

Q

What is the current price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $50 last updated November 12, 2024 at 4:00 PM EST.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There are no upcoming dividends for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch